Sanofi is proposing a new model for distributing drug discounts under the federal 340B program, according to the Wall Street ...

Eli Lilly and Novo Nordisk have filed dozens of lawsuits against compounding pharmacies marketing their own versions of ...

The Senate Judiciary Committee narrowly advanced a bill Thursday that would change the way the Patent Trial and Appeal Board ...

As the healthcare priorities of President-elect Donald Trump and his HHS pick Robert F. Kennedy Jr. take shape, one idea ...

Novo Nordisk and Viking Therapeutics took to the annual Liver Meeting to make the case for their experimental MASH drugs as ...

GSK’s linerixibat helped reduce itch in patients with a rare bile duct disease, meeting its primary endpoint in a late-stage ...

Venrock confirmed a new $500 million healthcare fund, separate from its $650 million fund announced in January. The filing ...

Aizen Ther­a­peu­tics has left stealth with $13 mil­lion in seed fund­ing and a mis­sion to ad­vance “mir­ror pep­tide” drug ...

Valora Therapeutics has $30 million to jumpstart research on immunotherapies based on sugars — the kind that dots cell ...

Chris Boshoff will become Pfizer's chief scientific officer and R&D president on January 1, replacing Mikael Dolsten. Roger ...

Novartis is acquiring Kate Therapeutics for $1.1 billion, focusing on gene therapy and neuroscience. CEO Vas Narasimhan and ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...